Prescription drug prices in the US.
出版信息
Med Lett Drugs Ther. 2017 May 22;59(1521):81-83.
PMID:28520697
Abstract
摘要
相似文献
1
Prescription drug prices in the US.美国的处方药价格。
Med Lett Drugs Ther. 2017 May 22;59(1521):81-83.
2
An Incomplete Prescription: President Trump's Plan to Address High Drug Prices.一项不完整的药方：特朗普总统解决高药价问题的计划。
JAMA. 2018 Jun 19;319(23):2373-2374. doi: 10.1001/jama.2018.7424.
3
Running short.快用完了。
Minn Med. 2011 Oct;94(10):8-10.
4
Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA.生物类似药和仿制药不太可能改变美国癌症药物的成本曲线。
Lancet Oncol. 2017 Jan;18(1):22-23. doi: 10.1016/S1470-2045(16)30653-2.
5
First biosimilar drug set to enter US market.首款生物类似药即将进入美国市场。
Nature. 2015 Jan 15;517(7534):253-4. doi: 10.1038/517253a.
6
Pharmaceuticals and Medical Devices: Cost Savings.药品和医疗器械：成本节约。
Issue Brief Health Policy Track Serv. 2015 Dec 28:1-31.
7
How to Reduce Prescription Drug Prices: First, Do No Harm.如何降低处方药价格：首先，不要造成伤害。
Mo Med. 2020 Jan-Feb;117(1):14-15.
8
A "Method of Use" to Prevent Generic and Biosimilar Market Entry.一种防止仿制药和生物类似药进入市场的“使用方法”。
N Engl J Med. 2023 Feb 9;388(6):483-485. doi: 10.1056/NEJMp2216020. Epub 2023 Jan 25.
9
Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry.制药行业中的反垄断、市场独占权与透明度
JAMA. 2018 Jun 12;319(22):2271-2272. doi: 10.1001/jama.2018.3478.
10
The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.美国处方药价格居高不下：根源与改革前景。
JAMA. 2016;316(8):858-71. doi: 10.1001/jama.2016.11237.
Zotero 插件